Stay updated on GSK2857916 Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.

Latest updates to the GSK2857916 Dose Escalation Clinical Trial page
- Check6 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a backend/template update to the study page. The visible content remains unchanged.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe study page now includes the disease term Multiple myeloma and a related topics link to MedlinePlus Genetics, improving context and discoverability. The revision tag has been updated from v3.6.4 to v3.6.5.SummaryDifference0.2%

- Check34 days agoChange DetectedA Study Documents section was added with links to PDFs (Study Protocol, SAP) and information about IPD sharing. It also includes an IPD Sharing URL and related resources, expanding access to documentation and data-sharing details for researchers and interested readers.SummaryDifference94%

- Check41 days agoChange DetectedThe page shows a new Revision: v3.6.4, indicating a site update; older study documents and related links were removed as part of that update.SummaryDifference23%

- Check48 days agoChange DetectedThe page now shows the condition 'Multiple myeloma' in the study context and adds a related topics area linking to MedlinePlus Genetics, improving access to disease context and related resources.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page no longer displays the disease term 'Multiple myeloma' and removes the related topics/MedlinePlus Genetics links. This reduces explicit disease context and external resources presented alongside the study.SummaryDifference0.1%

Stay in the know with updates to GSK2857916 Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.